HIV/HCV co-infection: Clinical and therapeutic challenges

AIDS

Volumn 16, Issue 10, 2002, Pages 1419-1420

  Ensoli, Fabrizio ^a   Caterina Sirianni, Maria ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Antiretroviral therapy; Hepatitis; Hepatotoxicity

Indexed keywords

ALPHA INTERFERON; ANTIRETROVIRUS AGENT; DIDANOSINE; PROTEINASE INHIBITOR; RIBAVIRIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZALCITABINE; ANTIVIRUS AGENT;

COMORBIDITY; DRUG EFFECT; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; LIVER INJURY; LIVER TOXICITY; MONOTHERAPY; PRIORITY JOURNAL; SHORT SURVEY; CHEMICALLY INDUCED DISORDER; LIVER DISEASE; NOTE; PATHOLOGY;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANTIVIRAL AGENTS; HEPATITIS C; HIV INFECTIONS; HUMAN; LIVER DISEASES; PROTEASE INHIBITORS; REVERSE TRANSCRIPTASE INHIBITORS; HUMANS;

EID: 0037024762     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200207050-00014     Document Type: Short Survey

References (16)

1. Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis
2. AIDS-related cancers in the era of highly active antiretroviral therapy
3. Adverse effects of antiretroviral therapy
4. Hepatitis C and human immunodeficiency virus coinfections
5. Is HCV co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy? Results from the Aquitaine cohort
6. Hepatitis B and C virus co-infection and the risk for hepatotoxicity of highly active antiretroviral therapy in HIV-1 infection
7. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection
8. Th1/Th2 cytokine profiles and their relationship to clinical features in patients with chronic hepatitis C virus infection
9. Chronic hepatitis C in HIV infection: Feasibility and sustained efficacy of therapy with interferon alfa-2b and tribavirin
10. Management of chronic hepatitis C in HIV-infected patients
11. Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfection
12. Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders
13. Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity
14. Mitochondrial toxicity in HIV-HCV coinfection: It depends on the choice of antiretroviral drugs?
15. Pharmacodynamics of human immunodeficiency virus type 1 protease inhibitor
16. Direct analysis of mitochondrial toxicity of antiretroviral drugs